Leukocyte-mediated Delivery of Nanotherapeutics in Inflammatory and Tumor Sites

Overview

Journal Theranostics

Date 2017 Mar 4

PMID 28255364

Citations 49

Authors

Xinyue Dong

Dafeng Chu

Zhenjia Wang

Affiliations

Soon will be listed here.

Abstract

Nanotechnology has become a powerful tool to potentially translate nanomedicine from bench to bedside. Nanotherapeutics are nanoparticles (NPs) loaded with drugs and possess the property of tissue targeting after surfaces of NPs are bio-functionalized. Designing smaller size of nanotherapeutics is presumed to increase tumor targeting based on the EPR (enhanced permeability and retention) effect. Since the immune systems possess a defence mechanism to fight diseases, there is an emerging concept that NPs selectively target immune cells to mediate the active delivery of drugs into sites of disease. In this review, we will focus on a key question of how nanotherapeutics specifically target immune cells and hijack them as a delivery vehicle to transport nanotherapeutics into disease tissues, thus possibly improving current therapies in inflammation, immune disorders and cancers. We will also discuss the challenges and opportunities for this new strategy of leukocyte-mediated delivery of nanotherapeutics.

Citing Articles

Development of Dual Diagnostic-Therapeutic Nanoformulation Effective Against Pancreatic Cancer in Animal Model.

Huang Y, Wang Y, Zheng T, Nie S, Wang Y, Shen H Int J Nanomedicine. 2024; 19:9121-9143.

PMID: 39258004 PMC: 11386073. DOI: 10.2147/IJN.S464788.

Targeted Delivery of Nanoparticle-Conveyed Neutrophils to the Glioblastoma Site for Efficient Therapy.

Piao C, Lee J, Kim G, Choe Y, Lee H, Hyun Y ACS Appl Mater Interfaces. 2024; 16(32):41819-41827.

PMID: 39057192 PMC: 11332397. DOI: 10.1021/acsami.4c05691.

Advances in Receptor-Mediated, Tumor-Targeted Drug Delivery.

Large D, Soucy J, Hebert J, Auguste D Adv Ther (Weinh). 2024; 2(1).

PMID: 38699509 PMC: 11064891. DOI: 10.1002/adtp.201800091.

Complement-dependent uptake of nanoparticles by blood phagocytes: brief overview and perspective.

Li Y, Moein Moghimi S, Simberg D Curr Opin Biotechnol. 2023; 85:103044.

PMID: 38091875 PMC: 11214757. DOI: 10.1016/j.copbio.2023.103044.

Multifunctional cell membranes-based nano-carriers for targeted therapies: a review of recent trends and future perspective.

Li M, Guo Q, Zhong C, Zhang Z Drug Deliv. 2023; 30(1):2288797.

PMID: 38069500 PMC: 10987056. DOI: 10.1080/10717544.2023.2288797.

References

Asma G, SCHUIT H, HIJMANS W . The determination of numbers of T and B lymphocytes in the blood of children and adults by the direct immunofluorescence technique. Clin Exp Immunol. 1977; 29(2):286-94. PMC: 1541100. View

Kolaczkowska E, Kubes P . Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol. 2013; 13(3):159-75. DOI: 10.1038/nri3399. View

Dinarello C . Anti-inflammatory Agents: Present and Future. Cell. 2010; 140(6):935-50. PMC: 3752337. DOI: 10.1016/j.cell.2010.02.043. View

Wang M, Yin B, Wang H, Wang R . Current advances in T-cell-based cancer immunotherapy. Immunotherapy. 2014; 6(12):1265-78. PMC: 4372895. DOI: 10.2217/imt.14.86. View

Barbara G, De Giorgio R, Stanghellini V, Cremon C, Corinaldesi R . A role for inflammation in irritable bowel syndrome?. Gut. 2002; 51 Suppl 1:i41-4. PMC: 1867730. DOI: 10.1136/gut.51.suppl_1.i41. View

Junt T, Moseman E, Iannacone M, Massberg S, Lang P, Boes M . Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells. Nature. 2007; 450(7166):110-4. DOI: 10.1038/nature06287. View

Peer D, Karp J, Hong S, Farokhzad O, Margalit R, Langer R . Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol. 2008; 2(12):751-60. DOI: 10.1038/nnano.2007.387. View

Bevaart L, Jansen M, van Vugt M, Verbeek J, van de Winkel J, Leusen J . The high-affinity IgG receptor, FcgammaRI, plays a central role in antibody therapy of experimental melanoma. Cancer Res. 2006; 66(3):1261-4. DOI: 10.1158/0008-5472.CAN-05-2856. View

Vanneman M, Dranoff G . Combining immunotherapy and targeted therapies in cancer treatment. Nat Rev Cancer. 2012; 12(4):237-51. PMC: 3967236. DOI: 10.1038/nrc3237. View

10.

Stylianopoulos T, Martin J, Chauhan V, Jain S, Diop-Frimpong B, Bardeesy N . Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors. Proc Natl Acad Sci U S A. 2012; 109(38):15101-8. PMC: 3458380. DOI: 10.1073/pnas.1213353109. View

11.

Pan R, Xu W, Yuan F, Chu D, Ding Y, Chen B . A novel peptide for efficient siRNA delivery in vitro and therapeutics in vivo. Acta Biomater. 2015; 21:74-84. DOI: 10.1016/j.actbio.2015.04.002. View

12.

Phillipson M, Kubes P . The neutrophil in vascular inflammation. Nat Med. 2011; 17(11):1381-90. PMC: 7095830. DOI: 10.1038/nm.2514. View

13.

Baeuerle P, Reinhardt C . Bispecific T-cell engaging antibodies for cancer therapy. Cancer Res. 2009; 69(12):4941-4. DOI: 10.1158/0008-5472.CAN-09-0547. View

14.

Wang Z . Caveolae-mediated Delivery of Therapeutic Nanoparticles across Blood-endothelial Barrier. Austin J Anal Pharm Chem. 2015; 1(4). PMC: 4662261. View

15.

Wang Z, Tiruppathi C, Cho J, Minshall R, Malik A . Delivery of nanoparticle: complexed drugs across the vascular endothelial barrier via caveolae. IUBMB Life. 2011; 63(8):659-67. PMC: 3142311. DOI: 10.1002/iub.485. View

16.

Shi C, Pamer E . Monocyte recruitment during infection and inflammation. Nat Rev Immunol. 2011; 11(11):762-74. PMC: 3947780. DOI: 10.1038/nri3070. View

17.

Heppner F, Ransohoff R, Becher B . Immune attack: the role of inflammation in Alzheimer disease. Nat Rev Neurosci. 2015; 16(6):358-72. DOI: 10.1038/nrn3880. View

18.

Hickey W . Leukocyte traffic in the central nervous system: the participants and their roles. Semin Immunol. 1999; 11(2):125-37. DOI: 10.1006/smim.1999.0168. View

19.

Xu W, Jafari M, Yuan F, Pan R, Chen B, Ding Y . In vitro and in vivo therapeutic siRNA delivery induced by a tryptophan-rich endosomolytic peptide. J Mater Chem B. 2020; 2(36):6010-6019. DOI: 10.1039/c4tb00629a. View

20.

Tufekci K, Meuwissen R, Genc S, Genc K . Inflammation in Parkinson's disease. Adv Protein Chem Struct Biol. 2012; 88:69-132. DOI: 10.1016/B978-0-12-398314-5.00004-0. View